IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells
暂无分享,去创建一个
M. Diamond | S. Manalis | D. Weinstock | Teemu P. Miettinen | K. Kume | M. Farzan | A. Thomas-Tikhonenko | H. Geng | Mark E. Robinson | M. Müschen | M. Nix | G. Xiao | Lars Klemm | Ning Ma | L. Chan | C. Chen | A. Wiita | N. Vaidehi | Kadriye Nehir Cosgun | V. Khairnar | T. Sadras | Jaewoong Lee | Gauri Deb | Mohamed A. Ahmed | Jianjun Chen | Jae U. Jung | Dewan Artadji | J. Winchester | Ye Zhang
[1] J. Knight,et al. Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019 , 2020, The Journal of infectious diseases.
[2] S. Manalis,et al. Non-invasive monitoring of single-cell mechanics by acoustic scattering , 2019, Nature Methods.
[3] C. Rice,et al. IFITM3 directly engages and shuttles incoming virus particles to lysosomes , 2019, Nature Chemical Biology.
[4] C. Robinson,et al. PIP2 stabilises active states of GPCRs and enhances the selectivity of G-protein coupling , 2018, Nature.
[5] L. Staudt,et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma , 2018, Nature.
[6] A. McMichael,et al. Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection , 2018, The Journal of infectious diseases.
[7] Jinhong Chang,et al. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses , 2017, Journal of Virology.
[8] Jumin Lee,et al. CHARMM‐GUI Martini Maker for modeling and simulation of complex bacterial membranes with lipopolysaccharides , 2017, J. Comput. Chem..
[9] Y. Li,et al. Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma , 2017, Thoracic cancer.
[10] S. Frietze,et al. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre–B ALL , 2017, The Journal of experimental medicine.
[11] M. D. Den Boer,et al. Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome , 2017, The Journal of experimental medicine.
[12] T. Graeber,et al. Metabolic gatekeeper function of B-lymphoid transcription factors , 2016, Nature.
[13] Jüergen Cox,et al. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.
[14] M. Diamond,et al. The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses , 2016, Journal of Virology.
[15] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[16] C. Tian,et al. Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3 , 2016, Scientific Reports.
[17] Helgi I Ingólfsson,et al. CHARMM-GUI Martini Maker for Coarse-Grained Simulations with the Martini Force Field. , 2015, Journal of chemical theory and computation.
[18] Qing-Yu He,et al. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..
[19] E. Passegué,et al. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia , 2015, Nature Communications.
[20] M. Farzan,et al. IFITM-Family Proteins: The Cell's First Line of Antiviral Defense. , 2014, Annual review of virology.
[21] M. Reth,et al. B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk , 2014, eLife.
[22] Nicholas M. Chesarino,et al. Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 (IFITM3) Dually Regulates Its Endocytosis and Ubiquitination* , 2014, The Journal of Biological Chemistry.
[23] Jiangwen Zhang,et al. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia , 2014, Nature Immunology.
[24] J. Zuber,et al. Stage-specific control of early B cell development by the transcription factor Ikaros , 2014, Nature Immunology.
[25] Siewert J Marrink,et al. Going Backward: A Flexible Geometric Approach to Reverse Transformation from Coarse Grained to Atomistic Models. , 2014, Journal of chemical theory and computation.
[26] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[27] Z. Hildenbrand,et al. Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia. , 2013, Cell reports.
[28] Jing Huang,et al. CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data , 2013, J. Comput. Chem..
[29] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[30] W F Drew Bennett,et al. Improved Parameters for the Martini Coarse-Grained Protein Force Field. , 2013, Journal of chemical theory and computation.
[31] M. Diamond,et al. The broad-spectrum antiviral functions of IFIT and IFITM proteins , 2012, Nature Reviews Immunology.
[32] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[33] O. Elemento,et al. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. , 2012, Cancer discovery.
[34] Paul Kellam,et al. IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.
[35] Shilei Ding,et al. The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization , 2012, Journal of Virology.
[36] Qiang Li,et al. KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis , 2011, Clinical Cancer Research.
[37] G. Cheng,et al. New developments in the induction and antiviral effectors of type I interferon. , 2011, Current opinion in immunology.
[38] Kevin K Dobbin,et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. , 2010, Blood.
[39] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[40] J. Downing,et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.
[41] David J. Adams,et al. The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus , 2009, Cell.
[42] Ruedi Aebersold,et al. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins , 2009, Nature Biotechnology.
[43] R. Arceci,et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study , 2009 .
[44] S. Manalis,et al. Weighing of biomolecules, single cells and single nanoparticles in fluid , 2007, Nature.
[45] D. Murray,et al. Plasma membrane phosphoinositide organization by protein electrostatics , 2005, Nature.
[46] J. Downing,et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. , 2003, Blood.
[47] L. Staudt,et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.
[48] Xiaoli Li,et al. The physiologic role of CD19 cytoplasmic tyrosines. , 2002, Immunity.
[49] K. Okkenhaug,et al. Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.
[50] M. Fujimoto,et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. , 2000, Immunity.
[51] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[52] R. Hodges,et al. Relationship of sidechain hydrophobicity and α‐helical propensity on the stability of the single‐stranded amphipathic α‐helix , 1995 .
[53] B. Koller,et al. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.
[54] Wilfred F. van Gunsteren,et al. A generalized reaction field method for molecular dynamics simulations , 1995 .
[55] M. Klein,et al. Nosé-Hoover chains : the canonical ensemble via continuous dynamics , 1992 .
[56] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[57] A. Kohn,et al. Early interactions of viruses with cellular membranes. , 1979, Advances in virus research.